Logotype for PROCEPT BioRobotics Corporation

PROCEPT BioRobotics (PRCT) investor relations material

PROCEPT BioRobotics Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for PROCEPT BioRobotics Corporation
Q3 2025 earnings summary4 Nov, 2025

Executive summary

  • Achieved Q3 2025 revenue of $83.3M, up 43% year-over-year, driven by strong U.S. and international growth, with U.S. revenue at $73.9M (+42% YoY) and international revenue at $9.4M (+53% YoY).

  • U.S. installed base reached 653 systems, a 47% increase year-over-year, with global install base at 835 systems.

  • Aquablation therapy is positioned as a leading BPH treatment, supported by robust clinical evidence and growing adoption.

  • Organizational changes and new leadership, including CEO transition and new Chief Marketing and Strategy Officer, aim to accelerate commercial execution and international expansion.

  • Initiatives to increase therapy awareness, patient activation, and improve procedure utilization are central to near- and mid-term strategy.

Financial highlights

  • Gross margin improved to 65% in Q3 2025, up from 63% in Q3 2024, with full-year 2025 guidance at 64–64.5%.

  • Operating expenses rose to $77.2M in Q3 2025, up from $59.3M, and are projected at $302M for FY2025.

  • Net loss was $21.4M in Q3 2025, with adjusted EBITDA loss narrowing to $7.4M from $12.4M YoY.

  • Cash, cash equivalents, and restricted cash stood at $297M as of September 30, 2025; long-term debt was $52M.

  • Revenue for the nine months ended September 30, 2025, was $231.7M, up 48% YoY; net loss for the period was $65.7M.

Outlook and guidance

  • FY2025 revenue guidance is $325.5M (+45% YoY), with FY2026 outlook at $410–$430M, representing 26–32% growth.

  • FY2025 gross margin expected at 64–64.5%; operating expenses at $302M; adjusted EBITDA loss of ~$35M.

  • FY2025 international revenue expected at $37.5M (+56% YoY); 213 new U.S. robotic systems and 52,000 handpieces projected.

  • Management expects continued revenue growth as the install base and utilization expand, especially in the U.S.

  • Analyst Day in February 2026 will provide multi-year guidance and updates on R&D and marketing priorities.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next PROCEPT BioRobotics earnings date

Logotype for PROCEPT BioRobotics Corporation
Piper Sandler 37th Annual Healthcare Conference2 Dec, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next PROCEPT BioRobotics earnings date

Logotype for PROCEPT BioRobotics Corporation
Piper Sandler 37th Annual Healthcare Conference2 Dec, 2025

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

PROCEPT BioRobotics Corporation is a medical technology company specializing in the development and commercialization of robotic systems for the treatment of urological conditions. The company’s primary focus is on addressing benign prostatic hyperplasia (BPH), offering minimally invasive solutions designed to improve precision, patient outcomes, and recovery times. Its robotic platform combines imaging, robotics, and software to enhance surgical accuracy and efficiency, supporting healthcare providers in delivering advanced care. PROCEPT BioRobotics Corporation is headquartered in Redwood City, California, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage